Dated Wet Lab work from our first assay brainstorms in March to the co-transformations in October 2026. Each entry records the goal, the work done, the result and the next step, compiled from our meeting slides, the experiment schedule, the assay design documents and the team's lab channels.
Journal
Chronological wet lab notes from meetings, lab shifts and the team's lab notes, newest first. Scroll through each entry below, or pick a date under Journal in the side menu to jump to a day.
October 5, 2026
Goal
Combine the assay plasmid with the display plasmid in one strain.
Work completed
Ran GGA of the empty PD with the five control PETases, PCR-checked the products, streaked AS-msGFP and AS-sul1, and co-transformed AS + PD (AS-msGFP + PD and AS-sul1 + PD) into BL21(DE3) on kan + amp plates. Started BL21(DE3) competent cells carrying each AS plasmid for serial transformations, and made more copper-stained mesh.
Result
Co-transformations plated; competent cells in progress for the serial-transformation route.
Next step
Test the controls on assay plates, and try a quick check suggested by Thomas: incubate copper PET mesh with FAST-PETase lysate, pour it over a lawn of the GFP strain, and look for fluorescence.
Figures


September 30, 2026
Goal
Assemble the control PD plasmids.
Work completed
Miniprepped and sequenced the PD backbone, PCR'd the PETase controls, ran GGA of the controls into PD, and prepared LB + kan + amp and MHA + kan + amp + IPTG (± sulfonamide) plates. Secured −80 °C freezer space in BioZone.
Result
The PD miniprep had high concentration and purity, and all control PD plasmids now exist. The first sequence library from Dry Lab was ordered. One KLD'd PD lost half its sequence, so a fresh PD was ordered.
Next step
Transform the AS and PD plasmids together into BL21(DE3).
September 22, 2026
Goal
Restart lab work in BioZone and clone the control PETases.
Work completed
RRFs approved; lab shifts resumed on September 24. Moved samples from the Lash Miller and BME labs into BioZone, took inventory, miniprepped the PD liquid cultures, and resuspended the Twist inserts (IsPETase, FAST-PETase, LCC-PETase, M4-Q PETase and a dead IsPETase).
Result
Wet Lab is fully based in BioZone, with control PETase inserts ready for assembly into the PD backbone.
Next step
Golden Gate each control PETase into the PD plasmid.
September 17, 2026
Goal
Prepare for the conference and wiki while RRFs are reviewed.
Work completed
Attended the BioZone orientation, built the Wet Lab poster on our assays for the UofT Microplastics Conference, and drafted the Wet Lab wiki sections (due September 18).
Result
Poster presented at the conference on September 19; wiki drafts submitted for review.
Next step
Resume lab shifts once Environmental Health and Safety approves the RRFs.
August 31, 2026
Goal
Finish at BME and move into BioZone.
Work completed
PCR-cleaned PD fragment 1, ran GGA of fragments 1 and 2, and transformed the product into DH5α on amp plates. August 31 was the last regular lab day at BME; samples and reagents were logged on an inventory sheet and moved to BioZone (room 403) on dry ice.
Result
PD fragments 1 and 2 through PCR and assembly; second BioZone lab tour completed.
Next step
Wait for the BioZone RRFs to be approved before starting lab work there.
August 24, 2026
Goal
Collect selection data and start the PD (display) plasmid.
Work completed
Photographed copper plates under blue light, tested AS-sul1 on kan + 32 µg/mL sulfonamide with varying copper and AS-sul2 on varying sulfonamide at 4 mM copper (10⁸–10² dilutions, empty AS control), glycerol-stocked and sequenced AS-empty and AS-dfr, and redid the empty PD transformation. Submitted all outstanding safety forms; Prof. Lawson signed the RRFs.
Result
AS-sul1 grows at higher sulfadiazine concentrations than the negative control: early evidence that the selection assay works. Copper loads reliably onto the PET test plates. PD fragment 1 PCR gave a clean band.
Next step
Assemble the PD plasmid from fragments 1 and 2 and move into BioZone.
Figures



August 17, 2026
Goal
Test the copper biosensor and check copper leaching from PET mesh.
Work completed
Imaged BL21 AS-msGFP2 on kan + CuSO₄ plates under UV and blue light. Grew AS-msGFP2 with copper-stained PET mesh placed on the plates (mesh washed once, twice or three times) to test leaching. Re-sequenced AS-sul2 and AS-dfr, and set up a new GGA of AS + pCusC-RBS + dfrB10.
Result
AS-msGFP2 responds to copper as designed: the team's first validated experimental result of the summer. Colonies touching washed mesh did not glow, so washed mesh does not leach detectable copper. AS-sul2 confirmed (4 of 5 samples); all AS-dfr samples carried the same mutations and deletions, so dfr was rebuilt.
Next step
Test AS-sul1 and AS-sul2 across sulfonamide and copper concentrations.
Figures

August 15, 2026
Goal
Confirm the cloned AS variants by sequencing.
Work completed
Reviewed the new sequencing results for each AS variant and planned constant-copper and constant-sulfonamide plate series (sulfonamide 0–250 µg/mL at 4 mM copper; copper series at 32 µg/mL sulfonamide).
Result
AS-msGFP2 confirmed (a single base-pair mismatch carried over from the backbone) and AS-sul1 confirmed. AS-dfr and AS-sul2 needed to be redone.
Next step
Transform AS-msGFP2 and AS-sul1 into BL21 and test them on copper plates.
Figures

August 11, 2026
Goal
Sequence the AS variants and test copper and dye release from PET.
Work completed
Miniprepped sul1, sul2, dfr and msGFP2 (mixing kit columns when one ran out) and sent them for sequencing. Ran the dye-release protocol and 24 h copper strip tests on PET mesh. Explored measuring copper sorption by comparing CuSO₄ concentration before and after adding mesh.
Result
First sequencing runs had few reads and genomic DNA contamination; sul2 and msGFP2 were usable, sul1 needed a fresh miniprep. The 5-minute stained mesh released noticeably more crystal violet than the longer stains. Copper test strips read falsely when NaOH is present, so neutralization is needed first. Four assays now in development: copper biosensor, selection, dye release and an in-house halo assay; a dead PETase arrived as a negative control.
Next step
Re-sequence the variants and test the biosensor strain on copper plates.
Figures


August 4, 2026
Goal
Clone the selection and biosensor variants of the AS plasmid.
Work completed
Ran GGA of the post-KLD AS plasmid with the sul1, sul2, dfr and msGFP2 inserts and transformed them into DH5α. Made Mueller Hinton plates across a range of CuSO₄ concentrations, ran copper toxicity spot plates and copper strip tests, and measured crystal violet absorbance at 590 nm after 5–40 min staining.
Result
Everyone has now passed the Lawson interview, so the whole roster can work at the bench. Undigested plasmids on a gel showed supercoiled/nicked mixtures, so gels now need digestion first.
Next step
Miniprep and sequence each AS variant; make TMP stock for the dfr plates.
Figures

July 27, 2026
Goal
Purify the AS plasmid, fix minipreps and start copper tests.
Work completed
Glycerol-stocked and miniprepped the AS plasmid, finished BL21 competent cells, made serial-dilution OD vials for Hardware's OD sensor testing, and began copper toxicity and copper-release-from-fabric tests. Placed Twist and IDT orders. Second Lawson interview held for the rest of the team.
Result
AS plasmid purified, competent cells made, and the miniprep protocol that had been failing is now solved. Copper phthalate made (blue precipitate; IR confirmation pending).
Next step
Golden Gate the selection and biosensor inserts into the AS plasmid.
Figures


July 20, 2026
Goal
Pass safety interviews and narrow the assay scope.
Work completed
Passed the first round of Lawson safety interviews (all leads and half the team). Made copper phthalate, stained fabric with copper, ran day 1–2 of BL21 competent cells, and transformed pUC19 into our own DH5α competent cells as a positive control. Received the AS plasmid sequencing.
Result
Scope sharpened to the copper-based biosensor and selection assays, with an August 1 checkpoint to show at least one assay is likely to work. Only the 20 mL culture's miniprep gave a full AS plasmid assembly.
Next step
Purify the AS plasmid and test copper toxicity.
July 16, 2026
Goal
Meeting #15: review the week and team feedback.
Work completed
Made competent cells, performed KLD on the AS plasmid fragment, PCR'd one of the two PD fragments to add Golden Gate cut sites, transformed the AS plasmid, made its glycerol stock and miniprepped it for sequencing. Collected feedback on documentation, lab-note structure and shift instructions.
Result
AS plasmid in hand and sent for sequencing. Weekly subgroup-lead meetings started; a 'What we did' section was added to the lab notes.
Next step
Prepare for the BioZone safety interview with Prof. Lawson (review RRFs).
July 14, 2026
Goal
Assemble the AS plasmid from IDT fragments.
Work completed
Day 1–2 of the Zymo competent cell protocol. KLD-circularized the linear IDT plasmids, PCR-amplified fragments with primers, ran Golden Gate assembly (GGA) on the PCR products and transformed the KLD and GGA products.
Result
KLD transformation produced colonies on the selection plate.
Next step
Pick colonies for liquid cultures and miniprep the AS plasmid.
July 8, 2026
Goal
First assay-specific protocols and the Wet Lab manifesto.
Work completed
Wrote protocols for loading copper into plastic and staining PETG fabric with dyes. Started expressing FAST-PETase in SHuffle T7, made Terrific Broth, and miniprepped the distribution plasmids (pDest, IsPETW, pRBS, EcCoWT, pJump26 and terminators) for sequencing. Completed the Wet Lab manifesto needed for order approvals.
Result
First round of protocols finished (copper compounds, fabric staining, concentrated PETase extraction) and the next reagent orders placed.
Next step
Make competent cells with the Zymo protocol and assemble the IDT fragments.
July 3, 2026
Goal
Get distribution-kit plasmids into DH5α and plan cloning.
Work completed
Held the cloning strategy meeting and placed IDT orders. Moved DH5α competent cells to −80 °C, resuspended selected distribution plasmids and transformed DH5α (plates split between two transformations each).
Result
All transformations worked (some colonies sparse on the EcCo and pTac plates). DH5α transformations are now reliable.
Next step
Grow cultures, miniprep and sequence the distribution plasmids; write protocols for copper and dye experiments.
June 22, 2026
Goal
Troubleshoot BL21 minipreps and transform the new NEB DH5α cells.
Work completed
Restreaked BL21 from glycerol stock, redid BL21 minipreps and NanoDrop readings, transformed NEB DH5α with distribution plasmids and grew 5 mL cultures. Set a rule that nothing stays in the incubators over the weekend after mould appeared on a plate.
Result
BL21 gave poor miniprep yields; switching to larger cultures or Terrific Broth (TB) and doubling lysis buffers was suggested. Selection-assay plasmids finalized with both sulfonamide and TMP resistance markers.
Next step
Hold the cloning strategy meeting and place DNA orders.
June 15, 2026
Goal
Run the first full lab week: transformations, minipreps and glycerol stocks.
Work completed
Inoculated SOB with DH5α, made DH5α competent cells, transformed BL21 with pUC19 and DH5α with distribution-kit plasmids, made liquid cultures, minipreps and glycerol stocks, and poured chloramphenicol, kanamycin and ampicillin plates. All members are now BME trained.
Result
Transformation workflow running Monday to Friday. The first plasmid design was finalized and its insert is ready to order.
Next step
Check miniprep yields with the NanoDrop and send good samples for sequencing.
June 11, 2026
Goal
Make competent cells and settle the selection assay design.
Work completed
Picked up cells from Thomas, grew liquid cultures and prepared Mix&Go and BL21 competent cells (OD600 read in flat 96-well plates). The Selection subgroup met to compare trimethoprim (TMP) vs sulfonamide selection, dfrA1 vs dfrB10 markers, inducer and promoter options, media and controls.
Result
First batch of competent cells made. Selection design questions laid out, with the biggest open risk identified before cloning.
Next step
Run the first full week of transformations and minipreps.
June 3, 2026
Goal
First days in the lab: set up reagents and basic media.
Work completed
Picked up the first reagent orders, organized and labelled them in the BME lab, and introduced lab-note taking. Prepared LB broth and LB agar, autoclaved at the Donnelly Centre and poured plates. Assay plans went to Jonas for review; RRF templates went out to all members.
Result
Lab space and media ready. Expert review of the assay plans came back positive, with a suggestion to try copper phthalate melted directly into PET as a substrate variant.
Next step
Finish RRFs by June 9 and schedule competent-cell prep and transformations.
May 25, 2026
Goal
Lock in the organism and get members cleared for the BME teaching lab.
Work completed
Ran the mandatory BME lab tour, made Wet Lab meetings in-person, opened an absence channel, and started the assay design master document (questions on copper-responsive promoters such as copAP and pCusC, and on loading copper into PET).
Result
Bacteria (E. coli) confirmed as the working organism; assay plans rewritten accordingly. Copper phthalate (rather than copper sulfate) chosen as the way to load copper into PET.
Next step
Complete EHS courses and the CHE summer training, and send the assay plans for expert review.
May 7, 2026
Goal
Restart weekly Wet Lab meetings for the summer and split into assay subgroups.
Work completed
Moved meetings to Thursdays 6–7 PM after exams. Introduced a team task tracker and lead office hours, confirmed access to the BME teaching lab alongside BioZone, and updated the assay ideas.
Result
Members assigned themselves to three assay subgroups; volunteers picked up the open research questions for the next meeting.
Next step
Finish assay research and start the safety paperwork needed for the BME lab.
March 19, 2026
Goal
Debrief the first two brainstorming sessions and narrow down assay ideas.
Work completed
Reviewed ideas from brainstorms 1 and 2: flow-cytometry droplets with a dye–quencher PET linker, clip-chemistry and SpyTag binding, fluorescein conjugation, and magnetic sorting. Presented the two front-runners at Meeting #2: surface collection (biotinylated PET bound by streptavidin, released by PETase onto a nickel-resin collection surface via a His tag) and a dropout assay (amino acids melted into PET, released by PETase to rescue auxotrophic cells).
Result
Surface collection and the dropout assay carried forward as the main concepts, with internal controls planned (catalytically dead, low- and high-activity PETases).
Next step
Research existing assays for overlap, continue safety training, join the team Benchling project, and hold the next brainstorm on March 29.



































